Germany Tenders
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Healthcare and Medicine
Germany
Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products with the active ingredient Natalizumab (l04aa23), SC dosage form as part of an open-house model.
Closing Date31 Aug 2025
Tender AmountRefer Documents
5921-5930 of 6310 active Tenders